Insiders · RNAZ

RNAZ insider transactions

TransCode Therapeutics Inc. (RNAZ) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RNAZ

• 124d
  SEC Form 3 filed by new insider Czerepak Elizabeth

  3 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 124d
  SEC Form 3 filed by new insider Stover Jack E

  3 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 676d
  SEC Form 4 filed by Director Marquet Magda

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 676d
  SEC Form 4 filed by Director Manting Erik

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 676d
  SEC Form 4 filed by Interim CEO, CFO Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 676d
  SEC Form 4 filed by Director Calais Philippe

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 936d
  Fitzgerald Thomas A bought $25,168 worth of shares (49,350 units at $0.51), increasing direct ownership by 708% to 56,318 units (SEC Form 4)

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 936d
  Dudley Robert Michael bought $49,980 worth of shares (98,000 units at $0.51), increasing direct ownership by 119% to 180,262 units (SEC Form 4)

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1038d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1046d
  SEC Form 4 filed by Dudley Robert Michael (Amendment)

  4/A - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1047d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Manting Erik

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Marquet Magda

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Calais Philippe

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1081d
  SEC Form 4 filed by Manting Erik

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1081d
  SEC Form 4 filed by Marquet Magda

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1081d
  SEC Form 4 filed by Calais Philippe

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1228d
  SEC Form 4 filed by Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1228d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1228d
  SEC Form 4 filed by Medarova Zdravka

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1228d
  SEC Form 4 filed by Medarova Zdravka

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1317d
  SEC Form 4: Dudley Robert Michael bought $23,000 worth of shares (20,000 units at $1.15), increasing direct ownership by 2% to 893,114 units

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1403d
  SEC Form 4 filed by Calais Philippe

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1403d
  SEC Form 4 filed by Marquet Magda

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1403d
  SEC Form 4 filed by Manting Erik

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1408d
  SEC Form 4: Fitzgerald Thomas A bought $15,240 worth of shares (12,000 units at $1.27), increasing direct ownership by 9% to 139,377 units

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1424d
  SEC Form 4: Dudley Robert Michael bought $55,383 worth of shares (30,000 units at $1.85), increasing direct ownership by 4% to 873,114 units

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1515d
  SEC Form 4 filed by Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1543d
  SEC Form 4 filed by Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1543d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)